Additional Details
-
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
Massachusetts General HospitalBoston MA. 02114 -
Move With Air: Physiological Response Assessment
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1 -
Move With Air: Exercise Training Study
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Arizona Pulmonary SpecialistsPhoenix AZ. 85012 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Summit HealthBend OR. 97701 -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Vincent Medical GroupIndianapolis IN. 46260 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteKansas City KS. 66062 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteCharleston SC. 29425 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteRochester MN. 55905 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteBirmingham AL. 35209 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteBaltimore MD. 21224 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SiteCleveland OH. 44195 -
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Molecure Investigative SitePhiladelphia PA. 19140 -
Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation
University of South Florida/ Tampa General HospitalTampa FL. 33606 -
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
University of Oklahoma Health Sciences Center (OUHSC)Oklahoma City OK. 73104-5417 -
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Southeastern Research CenterWinston-Salem NC. 27103-4007 -
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Metroplex Pulmonary and Sleep CenterMcKinney TX. 75069-1898 -
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Florida Lung Asthma and Sleep SpecialistCelebration FL. 34747-1818 -
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Bogan Sleep Consultants, LLCColumbia SC. 29201-2953